Trademark Attorney / Law Firm

Sarah Gulati, Esquire – Trademark Portfolio

Sarah Gulati, Esquire specializes in Class 41 (Education & Entertainment) trademark filings before the United States Patent and Trademark Office (USPTO), with 1 of 2 total filings concentrated in this category. The practice also covers Class 5 (Pharmaceuticals) along with 2 other Nice Classification classes. Filing activity spans from 2012 to 2017. Currently, 0 trademarks are registered.

2 Total Trademarks
Loading...
By Date
By Name
Filter by Class:

Practice Areas by Trademark Class

Sarah Gulati, Esquire's trademark practice covers 2 Nice Classification classes, representing the range of industries and goods/services handled in their USPTO filings.

41
Education & Entertainment (1 filing)

Education; providing of training; entertainment; sporting and cultural activities

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademark applications has Sarah Gulati, Esquire filed?

Sarah Gulati, Esquire has filed 2 trademark applications with the United States Patent and Trademark Office (USPTO).

What trademark classes does Sarah Gulati, Esquire specialize in?

Sarah Gulati, Esquire has filed trademarks across 2 Nice Classification classes. The most common practice areas include Class 41 (Education & Entertainment), Class 5 (Pharmaceuticals). Class 41 covers education; providing of training; entertainment; sporting and cultural activities.

How long has Sarah Gulati, Esquire been filing trademarks?

Sarah Gulati, Esquire's trademark filing history with the USPTO spans from 2012 to 2017, covering 5 years of trademark practice. During this period, Sarah Gulati, Esquire has handled 2 trademark applications.

What is Sarah Gulati, Esquire's trademark registration success rate?

Sarah Gulati, Esquire has a 0% trademark registration rate, with 0 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.